Cargando…
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To determine the efficacy of Hydroxychloroquine vs. Hydroxychloroquine + Nitazoxanide in reducing the need for invasive mechanical ventilatory support for patients with COVID-19. Hydroxychloroquine is currently being used in multiple trials with varying doses in an attempt to treat COVID...
Autores principales: | Calderón, José Meneses, Zerón, Hugo Mendieta, Padmanabhan, Srivatsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276957/ https://www.ncbi.nlm.nih.gov/pubmed/32513231 http://dx.doi.org/10.1186/s13063-020-04448-2 |
Ejemplares similares
-
Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital
por: Enríquez López, Krista Yazareth, et al.
Publicado: (2021) -
Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020) -
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
por: Allahyari, Abolghasem, et al.
Publicado: (2020) -
Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial
por: Pirjani, Reihaneh, et al.
Publicado: (2020) -
Hydroxychloroquine-induced erythroderma
por: Pai, Sunil B., et al.
Publicado: (2017)